These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Safety of air medical transportation after tissue plasminogen activator administration in acute ischemic stroke. Chalela JA; Kasner SE; Jauch EC; Pancioli AM Stroke; 1999 Nov; 30(11):2366-8. PubMed ID: 10548672 [TBL] [Abstract][Full Text] [Related]
29. Use of tissue-type plasminogen activator for acute ischemic stroke: the Cleveland area experience. Katzan IL; Furlan AJ; Lloyd LE; Frank JI; Harper DL; Hinchey JA; Hammel JP; Qu A; Sila CA JAMA; 2000 Mar; 283(9):1151-8. PubMed ID: 10703777 [TBL] [Abstract][Full Text] [Related]
30. Blood pressure management and evolution of thrombolysis-associated intracerebral hemorrhage in acute ischemic stroke. Mokin M; Kass-Hout T; Kass-Hout O; Zivadinov R; Mehta B J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):852-9. PubMed ID: 21703878 [TBL] [Abstract][Full Text] [Related]
31. Fibrinogen decrease after intravenous thrombolysis in ischemic stroke patients is a risk factor for intracerebral hemorrhage. Vandelli L; Marietta M; Gambini M; Cavazzuti M; Trenti T; Cenci MA; Casoni F; Bigliardi G; Pentore R; Nichelli P; Zini A J Stroke Cerebrovasc Dis; 2015 Feb; 24(2):394-400. PubMed ID: 25497721 [TBL] [Abstract][Full Text] [Related]
32. Pretreatment diffusion-weighted imaging lesion volume predicts favorable outcome after intravenous thrombolysis with tissue-type plasminogen activator in acute ischemic stroke. Kruetzelmann A; Köhrmann M; Sobesky J; Cheng B; Rosenkranz M; Röther J; Schellinger PD; Ringleb P; Gerloff C; Fiehler J; Thomalla G Stroke; 2011 May; 42(5):1251-4. PubMed ID: 21415399 [TBL] [Abstract][Full Text] [Related]
33. Early recurrent ischemic stroke in stroke patients undergoing intravenous thrombolysis. Georgiadis D; Engelter S; Tettenborn B; Hungerbühler H; Luethy R; Müller F; Arnold M; Giambarba C; Baumann CR; von Büdingen HC; Lyrer P; Baumgartner RW Circulation; 2006 Jul; 114(3):237-41. PubMed ID: 16831985 [TBL] [Abstract][Full Text] [Related]
34. The ALIAS Pilot Trial: a dose-escalation and safety study of albumin therapy for acute ischemic stroke--I: Physiological responses and safety results. Ginsberg MD; Hill MD; Palesch YY; Ryckborst KJ; Tamariz D Stroke; 2006 Aug; 37(8):2100-6. PubMed ID: 16809571 [TBL] [Abstract][Full Text] [Related]
35. Hourly blood pressure monitoring after intravenous tissue plasminogen activator for ischemic stroke: does everyone need it? Aiyagari V; Gujjar A; Zazulia AR; Diringer MN Stroke; 2004 Oct; 35(10):2326-30. PubMed ID: 15331797 [TBL] [Abstract][Full Text] [Related]
36. Current status of intravenous thrombolysis for acute ischemic stroke in Asia. Sharma VK; Ng KW; Venketasubramanian N; Saqqur M; Teoh HL; Kaul S; Srivastava PM; Sergentanis T; Suwanwela N; Nguyen TH; Lawrence Wong KS; Chan BP Int J Stroke; 2011 Dec; 6(6):523-30. PubMed ID: 22111797 [TBL] [Abstract][Full Text] [Related]
37. Safety of intravenous alteplase within 4.5 hours for patients awakening with stroke symptoms. Urrutia VC; Faigle R; Zeiler SR; Marsh EB; Bahouth M; Cerdan Trevino M; Dearborn J; Leigh R; Rice S; Lane K; Saheed M; Hill P; Llinas RH PLoS One; 2018; 13(5):e0197714. PubMed ID: 29787575 [TBL] [Abstract][Full Text] [Related]
38. Intravenous tissue plasminogen activator for acute ischemic stroke in patients aged 80 years and older : the tPA stroke survey experience. Tanne D; Gorman MJ; Bates VE; Kasner SE; Scott P; Verro P; Binder JR; Dayno JM; Schultz LR; Levine SR Stroke; 2000 Feb; 31(2):370-5. PubMed ID: 10657408 [TBL] [Abstract][Full Text] [Related]
39. Recanalization between 1 and 24 hours after t-PA therapy is a strong predictor of cerebral hemorrhage in acute ischemic stroke patients. Kimura K; Iguchi Y; Shibazaki K; Kobayashi K; Uemura J; Aoki J; Yamashita S; Terasawa Y; Matsumoto N J Neurol Sci; 2008 Jul; 270(1-2):48-52. PubMed ID: 18304581 [TBL] [Abstract][Full Text] [Related]
40. New appearance of extraischemic microbleeds on T2*-weighted magnetic resonance imaging 24 hours after tissue-type plasminogen activator administration. Kimura K; Aoki J; Shibazaki K; Saji N; Uemura J; Sakamoto Y Stroke; 2013 Oct; 44(10):2776-81. PubMed ID: 23887835 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]